Clinics and outpatient facilities that want to offer ketamine-based treatments for treatment-resistant depression often face a practical barrier: consistent access to psychiatric expertise for evaluations, treatment planning, and ongoing medication management. FasPsych’s telepsychiatry staffing solves this by connecting organizations with board-certified psychiatrists and psychiatric nurse practitioners who can support ketamine and esketamine care pathways through secure telemedicine—including e-prescribing ketamine in correctly supervised circumstances.
FasPsych providers work within applicable clinical and regulatory frameworks. When the clinical setting, patient selection, monitoring plan, and supervision requirements are appropriate, FasPsych clinicians can e-prescribe ketamine. For FDA-approved Spravato (esketamine nasal spray), administration remains restricted to certified healthcare settings under the REMS program. For other ketamine formulations used off-label, prescribing occurs only when the circumstances support safe, supervised use. For a detailed comparison of IV ketamine and Spravato, including FDA approvals and evidence, see our overview of ketamine nasal spray and IV treatments.
Ketamine Clinic Virtual Staffing with FasPsych
Ketamine clinic virtual staffing is one of the most practical ways FasPsych supports programs that offer esketamine nasal spray or coordinated ketamine care. Instead of hiring, credentialing, and managing full-time psychiatrists, clinics gain flexible access to licensed providers who handle the psychiatric components of the program remotely.
What virtual staffing typically includes:
- Scheduled or on-demand psychiatric evaluations for new and existing patients
- E-prescribing of ketamine in correctly supervised circumstances, plus concurrent medications
- Ongoing medication management and between-session follow-up
- Coordination notes shared with the clinic’s on-site administration and monitoring team
- Coverage for vacation, volume spikes, or new program launches
- Documentation that integrates with the clinic’s existing workflows
This model is especially useful for clinics focused on Spravato or supervised ketamine protocols. The on-site team manages administration and the required post-dose monitoring, while FasPsych providers supply the psychiatric evaluation, prescribing, and continuity that keep the program running smoothly. Clinics can start with limited hours and scale coverage as patient volume grows, paying only for the clinical time used.
What Telemedicine Can Support in Ketamine Care
What FasPsych telepsychiatry supports:
- Comprehensive psychiatric evaluations to determine whether a patient is an appropriate candidate
- Review of prior treatment history and confirmation of treatment-resistant depression criteria
- Prescription recommendations and e-prescribing of ketamine in correctly supervised circumstances
- E-prescribing of concurrent medications (such as oral antidepressants) used alongside ketamine or Spravato
- Ongoing monitoring of response, side effects, and mood between treatment sessions
- Coordination notes and treatment planning shared with the clinic’s on-site team
- Urgent or on-demand follow-up when questions arise between sessions
Supervision and administration requirements remain important:
- Spravato must be administered in a certified healthcare setting under the FDA-mandated REMS program, with at least two hours of post-dose monitoring
- IV ketamine and other formulations require appropriate clinical supervision consistent with standards of care and applicable regulations
- Immediate post-dose observation and vital sign monitoring stay with the treating facility when required
This model allows clinics to expand access while keeping prescribing, supervision, and monitoring aligned with safety requirements. Clinics seeking background on the treatments themselves can review our guide to ketamine nasal spray and IV ketamine for depression.
How the FasPsych Clinic Partnership Works
- Initial Psychiatric Evaluation via Telemedicine
A FasPsych psychiatrist or psychiatric nurse practitioner conducts a thorough virtual assessment. This includes diagnostic confirmation, review of previous antidepressant trials, medical history screening, and discussion of risks and benefits. Clinics can schedule these evaluations on-demand or as part of a dedicated coverage model. Virtual mental health evaluations are a core FasPsych service. - Treatment Planning and E-Prescribing
Based on the evaluation, the FasPsych provider creates a clear treatment plan. When the circumstances are clinically appropriate and properly supervised, the provider can e-prescribe ketamine. Concurrent medications (such as an oral antidepressant when used with Spravato) can also be e-prescribed. Recommendations and prescriptions are documented and shared with the clinic’s team so care can proceed safely. Adult psychiatric services support this ongoing medication management. - Coordination with On-Site Teams
FasPsych clinicians communicate with the clinic’s staff regarding eligibility, monitoring considerations, and any specifics of the prescribed regimen. This supports continuity between the telemedicine evaluation and in-person or supervised components of care. - Between-Session and Maintenance Follow-Up
After initiation, patients often need ongoing psychiatric support. FasPsych providers handle follow-up visits via telemedicine to assess response, manage side effects, adjust medications, and plan maintenance treatment. On-demand psychiatry and hybrid telemedicine options make this flexible for clinics of any size. - Documentation and Compliance Support
All visits are documented in a HIPAA-compliant manner and can integrate with the clinic’s existing EHR. Providers follow applicable state licensing requirements and standard of care guidelines, including any supervision or monitoring conditions tied to the prescription. Access FasPsych’s nationwide provider network for licensed coverage across states.
Regulatory Context Clinics Should Know
Spravato is FDA-approved for treatment-resistant depression (including as monotherapy as of 2025) and for depressive symptoms in major depressive disorder with acute suicidal ideation or behavior. It is available only through the Spravato REMS program, which requires certified settings and supervised administration. IV ketamine and other formulations used for depression are off-label; their use is guided by clinical evidence and expert consensus, including the 2017 American Psychiatric Association statement.
FasPsych’s e-prescribing of ketamine occurs only in correctly supervised circumstances that align with these frameworks. Clinics remain responsible for ensuring the physical setting, staffing, and monitoring meet the requirements of the specific treatment and applicable regulations.
Benefits for Clinics and Outpatient Facilities
- Scale ketamine or Spravato programs without recruiting and credentialing full-time psychiatrists
- Obtain psychiatric evaluations and e-prescribing support through a single telepsychiatry partner
- Maintain continuity of care even when patients require supervised administration sessions
- Access licensed providers across multiple states through FasPsych’s nationwide network
- Use flexible staffing models—scheduled coverage, hybrid, or on-demand—and pay only for clinical time used
Frequently Asked Questions
Can FasPsych providers e-prescribe ketamine?
Yes. FasPsych psychiatrists and psychiatric nurse practitioners can e-prescribe ketamine in correctly supervised circumstances that meet clinical and regulatory standards. For Spravato specifically, administration remains limited to certified healthcare settings under the REMS program.
What is ketamine clinic virtual staffing?
It is the use of telepsychiatry providers to handle psychiatric evaluations, e-prescribing (where appropriate), medication management, and follow-up for patients in a ketamine or Spravato program, while the clinic manages on-site administration and monitoring.
What kinds of prescriptions can FasPsych clinicians write for these patients?
FasPsych providers can e-prescribe ketamine (when circumstances are appropriate and supervised), oral antidepressants, and other psychiatric medications as clinically indicated. All prescribing is based on a proper evaluation and documented treatment plan.
Do patients need an in-person visit before starting treatment?
Requirements vary by state, by formulation, and by specific program rules (especially under Spravato REMS). FasPsych providers work within applicable regulations and coordinate with the clinic to ensure all necessary steps are completed.
How quickly can a clinic get psychiatric coverage for a ketamine program?
FasPsych offers flexible models, including on-demand evaluations. Many organizations begin with scheduled or hybrid coverage and expand as volume grows.
Is this model appropriate for both Spravato and other ketamine formulations?
Yes. The evaluation, planning, e-prescribing (where appropriate), and follow-up needs are similar. The clinic’s role in providing the correct level of supervision and monitoring is essential in every case.
Partner with FasPsych to Support Your Ketamine Program
Clinics that want to offer or expand ketamine-based treatments need reliable psychiatric expertise for evaluations, e-prescribing in correctly supervised circumstances, and ongoing management. FasPsych has provided telepsychiatry staffing to organizations nationwide since 2007, delivering these services through secure telemedicine.
Partner with FasPsych to discuss how virtual staffing can support your clinic’s ketamine or esketamine pathway.
This content is for informational purposes only and does not constitute medical advice. Treatment decisions and prescribing must be made by qualified clinicians in accordance with applicable laws, regulations, and standards of care. Spravato administration is restricted to certified settings under the REMS program. Refer to the official Spravato prescribing information for current regulatory details.